Eric Pulier is considered to be one of the more fascinating entrepreneurs in the tech industry over the past decade. Pulier came up alongside of the internet as a child and he grew into his fascination with technology at the same time. Pulier is now the founder of XPrize, a vaunted foundation focused on technological innovation, as well as the founder of numerous other tech companies — including vAtomic Systems. Eric Pulier’s ascent to the top of the industry has been remarkable to watch and sufficient to say, we are digging right into it.
Eric Pulier can tell you right off of the bat that he wouldn’t be where he is today without a childhood that was dedicated to technology that he fell in love with. By the time Pulier was in fourth grade he was already spending massive amounts of time learning how to code. By the time Pulier graduated from high school he had already been running his own computer database company — and this was only in the 1980s’! Pulier moved on quickly from his home in New Jersey in order to attend Harvard where he would go on to graduate Magna Cum Laude. At Harvard Pulier would cut his teeth as the editor of the school paper, the Harvard Crimson in the following: http://www.wingsjournal.com/eric-pulier-shares-12-travel-tips-business-trip click here.
Landing in Los Angeles in the early ’90s meant that Pulier was on the ground floor of what would soon become the huge tech boom. Knowing how to operate within the industry is all about spotting trends, watching companies, and making a move right when it is most opportune. Pulier succeeded by shifting gears from the medical industry into the education sector before breaking through as a tech innovator.
Nowadays Pulier is focused on doing what he does best: staying ahead of the competition. Pulier relies on his meticulous notes, his forward thinking instincts, and his willingness to take risks in order to stay ahead of the best in the business. Pulier is busy with his work at vAtomic Systems, a micro transaction company, but he is also interested in biotechnology such as genome editing with the CIRSPR-CAS9.